News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Agios Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
AWARDS
NEWS
Biotech Bay
Top 5 Biotech Stocks to Buy for 2018
A new RBC report is reasonably positive on the biotech sector for 2018 and here are some reasons why.
December 21, 2017
·
2 min read
·
Mark Terry
FDA
Agios, Celgene Win Early FDA Approval for New Cancer Drug
August 1, 2017
·
2 min read
Drug Development
Cambridge Biotech Agios Terminates AG-519 for PK Deficiency, But Continues AG-348 For Same Condition
December 16, 2016
·
2 min read
FDA
Another Celgene Bet Pays Off as Agios Eyes Early Approval of Leukemia Drug
September 7, 2016
·
2 min read
Business
Former BIND Therapeutics CEO Joins Agios as New CFO
August 16, 2016
·
2 min read
Business
Agios, Celgene Hammer Out $1 Billion+ Metabolic Immuno-Oncology Deal
May 18, 2016
·
3 min read
Genetown
10 Massachusetts Biotechs Devoting the Most Cash to R&D
May 5, 2016
·
3 min read
Genetown
Celgene And Agios Deliver Some Great “Bad” News
June 18, 2015
·
1 min read
Business
Celgene Dealmaking Continues With Two Pacts Worth $110 Million With Agios, Northern Biologics
April 29, 2015
·
3 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth
January 12, 2026
·
10 min read
Press Releases
Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 5, 2026
·
1 min read
Press Releases
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
December 24, 2025
·
15 min read
Press Releases
Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia
December 8, 2025
·
4 min read
Press Releases
Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease
November 20, 2025
·
17 min read
Press Releases
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
November 4, 2025
·
12 min read
Press Releases
Agios Reports Third Quarter 2025 Financial Results and Provides Business Update
October 30, 2025
·
10 min read
Press Releases
Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia
October 20, 2025
·
10 min read
Press Releases
Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia
October 20, 2025
·
4 min read
Press Releases
Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET
October 17, 2025
·
1 min read
